Addax Biosciences is pleased to announce its selection as a finalist for the “Premio PMI Innovativa Piemonte 2024″ a prestigious accolade promoted by InnovUp, with the support of Bioindustry Park Silvano Fumero S.p.A. Società Benefit, Environment Park, and the Piemonte Innovation Cluster Network, aimed at recognizing the most groundbreaking SMEs in the region.
The winner will be announced on November 26, 2024, at 2:00 PM, at the Bioindustry Park in Colleretto Giacosa (TO), during an award ceremony that will provide ample opportunities for networking, exchanging ideas, and developing new collaborative initiatives. The event will also feature representatives from the Piemonte Region and key local and international networks, making it a valuable occasion for supporting innovation.
The selection of Addax Biosciences among the finalists is attributed primarily to the company’s flagship project: the development and validation of GAF®, a safe alternative fixative to formalin. GAF® is designed to safeguard the health of healthcare professionals while ensuring diagnostic precision.
GAF® offers optimal tissue fixation and enhanced nucleic acid preservation for advanced molecular profiling techniques, effectively overcoming the artifacts and poor DNA preservation associated with formalin fixation. The true innovation of Addax Biosciences’ fixative lies in its non-carcinogenic formulation, providing maximum safety for healthcare operators.
We are proud that this project has been recognized for its originality and significance. We sincerely thank the award organizers for this valuable opportunity and look forward with great anticipation to the final results of the competition, confident that it will be a day full of insights and opportunities for growth and innovation.